PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.

PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:

  • Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
  • Assessment of regulatory needs (ARN).
  • Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.

A summary of all the substance-specific activities can be found under ‘Details’ for each entry.

diuron (ISO); 3-(3,4-dichlorophenyl)-1,1-dimethylurea

EC / List no: 206-354-4 CAS no: 330-54-1
Data generation and assessment
DEv - Dossier evaluation
DEv 1
Scope
Targeted
Status
Concluded
Decision date
Decision
Latest update
26-Lis-2022
Additional information
ECHA has performed an assessment and did not issue a decision.
More information View
SEv - Substance evaluation (Community Rolling Action Plan (CoRAP))
SEv 1
Evaluating Member State
Finland
Co-Evaluating Member State
Initial grounds for concern
Potential endocrine disruptor
Other exposure/risk based concern
Wide dispersive use
Year
2014
Status
Concluded
Conclusion document
Latest update
24-Čer-2024
More information View
ED - Endocrine disruptor assessment
ED 1
Authority
Denmark
Status
Under development
Outcome
Under development (BPR)
Hazard assessment outcome document
Remarks
Concern
Endocrine disruption
Date of intention
02-Zář-2022
Date of hazard assessment
Latest update
20-Říj-2022
More information View
ED 2
Authority
Finland
Status
Concluded
Outcome
ED ENV
inconclusive
Hazard assessment outcome document
Remarks
The concern for endocrine disruption (human health) can be considered inconclusive as the information available is neither sufficient for identifying the Substance as an endocrine
disruptor for human health nor for excluding the concern.
Concern
Endocrine disruption
Date of intention
03-Úno-2012
Date of hazard assessment
18-Čer-2024
Latest update
05-Čvc-2024
More information View
Regulatory risk management
CLH - Harmonised classification and labelling
CLH 1
Status
Opinion Adopted
Date of intention
06-Zář-2018
Withdrawal date
Submitter
Germany
Proposed harmonised classification by the dossier submitter
Carc. 1B, H350
STOT RE 2, H373
Aquatic Acute 1, H400
Aquatic Acute 1, M-factor=100
Aquatic Chronic 1, H410
Aquatic Chronic 1, M-factor=100
Remarks
Date of opinion
16-Zář-2021
RAC Opinion
Latest update
29-Lis-2022
More information View

List entry date: 14-Led-2016

Export search results to: